#CAS9
RRIDs were included in this in Stem Cell Research paper. We value the author's support of reproducibility. #reproducibility #BetterScience #RRID
Generation of CD43-P2A-mNeonGreen reporter human pluripotent stem cell line using CRISPR Cas9
Read the full paper: Generation of CD43-P2A-mNeonGreen reporter human pluripotent stem cell line using CRISPR Cas9
doi.org
November 8, 2026 at 8:01 AM
AI integration into CRISPR-Cas9 genome editing is advancing precision and safety, key for medical applications from genetic disorders to regenerative medicine.

🔗 Source: https://pubmed.ncbi.nlm.nih.gov/42987985/
November 7, 2026 at 9:36 AM
Check out our paper on therapeutic vulnerabilities of the human fungal pathogen Cryptococcus neoformans. We describe a method we call CRISPR-insert for genome mutagenesis. This is the first genome-wide CRISPR/Cas9 method implemented and validated in any fungal pathogen (to our knowledge). 1/3
November 5, 2026 at 9:55 PM
Congrats to Prof. Giulia Palermo on receiving an NIH/NIGMS ESI MIRA (R35) award! The grant will support the Palermo Labs' (@giuliapalermo.bsky.social) work integrating AI and molecular simulations to advance more efficient and precise CRISPR-Cas9 genome editing. Link: ucla.in/4ezv6Ld
November 9, 2026 at 6:12 PM
RRIDs were included in this in bioRxiv paper. We value the author's support of reproducibility. #BetterScience #OpenResearch #reproducibility
High-resolution CRISPR/Cas9 screens identify PAK2 as a suppressor of macrophage proliferation
Read the full paper: High-resolution CRISPR/Cas9 screens identify PAK2 as a suppressor of macrophage proliferation
doi.org
November 7, 2026 at 8:01 AM
Cas9 DSBs are often repaired by sister chromatid exchange—invisible to conventional WGS. sci-L3-Strand-seq maps Cas9-induced SCE genome-wide across single and >200 sites in human cells, linking hidden SCE to structural variation risk.
https://doi.org/10.7554/eLife.112073
November 9, 2026 at 1:23 AM
NanoPAMDA enables rapid PAM characterization of metagenome-derived Cas9 effectors https://www.biorxiv.org/content/10.64898/2026.11.04.764188v1
November 5, 2026 at 11:32 AM
CRV Science News
🧬 CRISPR-Cas9 Depletion of Ubiquitous Ribosomal and Mitochondrial cDNA Halves Sequencing Depth Requirements in Human Intestinal Single-Cell Transcriptomics — Single-cell RNA sequencing (scRNA-seq) has transformed m…

https://crvscience.com/news/crispr-cas9-rna-depletion-intestinal
CRV Science News 🧬 CRISPR-Cas9 Depletion of Ubiquitous Ribosomal and Mitochondrial cDNA Halves Sequencing Depth Requirements in Human Intestinal Single-Cell Transcriptomics — Single-cell RNA sequencing (scRNA-seq) has transformed mucosal immunology and gastroenterology by resolving the transcript…
crvscience.com
November 10, 2026 at 11:15 PM
🌱 How can we breed more resilient soybeans?
This review shows how #CRISPR #GenomeEditing can help improve stress tolerance, nutrition and key crop traits, and addresses technical and regulatory challenges.
doi.org/10.3389/fgee...
Frontiers | CRISPR/Cas9 in soybean research: a measured leap toward genetic refinement
Soybean [Glycine max (Linn.) Merr] is a globally important source of plant-based protein and edible oil, widely cultivated in India as a major oilseed crop. ...
doi.org
November 9, 2026 at 2:25 PM
The study replaced Cas9 with Cas12a to deliver a DNA-destroying enzyme to tumor cells once specific mutations are detected. This mechanism converts a detection event into a guided missile-like destruction of the cell's genetic material.

#Crispr #Cas12a #Cancer
Researchers replaced Cas9 with Cas12a to destroy DNA
Source: Hackaday
realfeedapp.com
November 11, 2026 at 7:20 AM
In 2012, scientists turned a bacterial defense against viruses into DNA scissors: a guide RNA leads Cas9 to a chosen spot, and it cuts.

2020: Nobel Prize for Charpentier and Doudna. 2023: the first CRISPR therapy, for sickle cell disease.

#CRISPR #Science #GeneEditing
November 9, 2026 at 2:14 PM
And of course there were intervening steps, not the least of which was the development of that discovery into the Nobel-winning CRISPR-Cas9 tool by Jennifer Doudna and Emmanuelle Charpentier in 2012, and the teams at Vertex Pharmaceuticals and CRISPR Therapeutics who turned it into "Casgevy"
November 10, 2026 at 1:43 PM
The authors included RRIDs in their in Applied Microbiology and Biotechnology paper! RRIDs improve reproducibility in scientific research. #ReproducibleResearch #BetterScience #RRID
An improved CRISPR-Cas9 protein-based method for knocking out insect Sf9 cell genes
Read the full paper: An improved CRISPR-Cas9 protein-based method for knocking out insect Sf9 cell genes
doi.org
November 6, 2026 at 8:00 AM
NanoPAMDA enables rapid PAM characterization of metagenome-derived Cas9 effectors https://www.biorxiv.org/content/10.64898/2026.11.04.764188v1
November 5, 2026 at 11:32 AM
📈 Beyond Conventional CRISPR: Next-Generation Gene Editing

While conventional CRISPR-Cas9 treatments have reached the market, pioneers are advancing alternative methodologies.

🔗 Read the full story on GazeWire

#Markets #Biotech #Crispr #GazeWire
📈 Beyond Conventional CRISPR: Next-Generation Gene Editing
While conventional CRISPR-Cas9 treatments have reached the market, pioneers are advancing alternative methodologies.
gazewire.com
November 6, 2026 at 2:35 AM
Job ID: 26FA0535
Extract: Postdoctoral position in Rutgers-Camden Biology to study EGFR signaling evolution using CRISPR/Cas9 and molecular biology in Drosophila. NIH-funded, renewable based on funding.
November 9, 2026 at 3:21 AM
🧬 New preprint! NanoPAMDA profiles PAM preferences of many Cas9 orthologs at once on a Nanopore.

We mined 620k genomes + human microbiome reads and profiled 14 candidates. E10, from a mouse gut metagenome, is functional, with an NGG-like PAM. www.biorxiv.org/content/10.6...
November 6, 2026 at 7:37 AM
The sperm-specific phospholipase C isoform PLCζ1 initiates fertilization Ca2+ oscillations in mammals, yet its loss does not eliminate #fertility. This study shows that PLCδ4 is a crucial backup oscillator supporting robust fertilization in mammals.
🧪 #AcademicSky #reproduction
plos.io/3VaGHtq
November 9, 2026 at 5:04 PM
IOCAS researchers established the first vector-based #CRISPR-Cas9 platform in green tide macroalga Ulva prolifera, driven by dual-transcribing U6 promoters that trigger 92.3% editing efficiency and targeted MULE transposon insertions. 🌿🤖 #UlvaProlifera #Macroalgae #BioRxiv2026 #MarineBiotech #CAS
November 10, 2026 at 1:50 AM
The sperm-specific phospholipase C isoform PLCζ1 initiates fertilization Ca2+ oscillations in mammals, yet its loss does not eliminate #fertility. This study shows that PLCδ4 is a crucial backup oscillator supporting robust fertilization in mammals.
🧪 #AcademicSky #reproduction
plos.io/3VaGHtq
November 8, 2026 at 1:02 PM
Genetic disruption of cutaneous de novo glucocorticoid synthesis: a CRISPR-Cas9 CYP11B1-knockout human epidermal model https://www.biorxiv.org/content/10.64898/2026.11.03.764005v1
November 4, 2026 at 1:30 PM